4TEEN4 Pharmaceuticals GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.4teen4.de
Clinical Trials
3
Active:1
Completed:1
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Procizumab (PCZ; AK1967) in Critical Cardiovascular Care
Phase 1
Recruiting
- Conditions
- Shock, Cardiogenic
- Interventions
- Drug: AK1967 (Procizumab)Drug: Placebo
- First Posted Date
- 2025-02-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- 4TEEN4 Pharmaceuticals GmbH
- Target Recruit Count
- 130
- Registration Number
- NCT06832722
- Locations
- 🇧🇪
University Hospital Saint Pierre, Brussels, Belgium
🇨🇿General University Hospital in Prague - FVN, Prague, Czechia
🇨🇿Institute of Clinical and Experimental Medicine - IKEM, Prague, Czechia
Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)
Phase 1
Completed
- Conditions
- Safety and TolerabilityHealthy Volunteers
- Interventions
- Drug: AK1967 (Procizumab)Drug: Placebo
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- 4TEEN4 Pharmaceuticals GmbH
- Target Recruit Count
- 24
- Registration Number
- NCT06331884
- Locations
- 🇳🇱
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands
News
No news found